2025-01-17 06:05:39
Innovent and AnHeart Announce Interim Data from Phase 2 Trial of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting
Corporate/ 2023-07-23
Innovent and AnHeart Announce Interim Da...

SAN FRANCISCO and SUZHOU,China,Sept. 27,2021-- Innovent Biologics,Inc. (Innovent) (HKEX: 01801),a world-class biopharmaceutical company that...

Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002
Health/ 2023-07-22
Transcenta Received IND Clearance from N...

SUZHOU,China,Sept. 27,2021-- Transcenta Holding Limited ("Transcenta"),a clinical stage biopharmaceutical company with fully-integ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release